Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation (AutoHCT)
Year: 2014
Type: article
Abstract: High-dose therapy with AutoHCT is a standard component of therapy for many patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Choice of high-dose therapy regimens has historically been driven by institutional tradition. No randomized prospective clinical trials have shown a difference in outcomes between conditioning regimens.
Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital, Medical College of Wisconsin, Banner MD Anderson Cancer Center, University Hospitals Cleveland Medical Center, Ottawa Hospital, Karolinska University Hospital, King Faisal Specialist Hospital & Research Centre, University of Chicago, University of Chicago Medical Center, Roswell Park Comprehensive Cancer Center, Johns Hopkins University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W4248955004